The evidence base for non-CF bronchiectasis is finally evolving

Respirology. 2014 Apr;19(3):295-7. doi: 10.1111/resp.12247.

Author

David J Serisier¹

Affiliation

¹ Department of Respiratory Medicine, Mater Adult Hospital, South Brisbane, Queensland, Australia; Immunity, Infection, and Inflammation Program, Translational Research Institute, Mater Research Institute-University of Queensland, Woolloongabba, Queensland, Australia.

PMID: 24620757
DOI: 10.1111/resp.12247

No abstract available

Keywords: azithromycin; bacterial drug resistance; bronchiectasis; erythromycin; macrolide.

Publication types

Editorial
Comment

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Bronchiectasis / drug therapy*
Cystic Fibrosis / drug therapy*
Humans
Macrolides / therapeutic use*

Substances

Anti-Bacterial Agents
Macrolides